Risk factors for pancreatic cancer

被引:125
作者
Lowenfels, AB [1 ]
Maisonneuve, P
机构
[1] New York Med Coll, Dept Surg, Valhalla, NY 10595 USA
[2] European Inst Oncol, Milan, Italy
关键词
pancreas; cancer; risk factors; epidemiology;
D O I
10.1002/jcb.20461
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the United States, the cumulative mortality or lifetime risk of dying from pancreatic cancer is about 1-2%, but although this form of cancer is rare, nearly a 11 patients die from the disease with in one to two years. Because of its lethality, pancreatic cancer now ranks fourth as a Cause of death from cancer. There are country-specific differences in rates, perhaps explained by differences in life-style factors or diet. African-Americans in the USA have rates that are about 50% higher than Caucasians. Smoking is the major known risk factor for this cancer, explaining 20-30% of all cases. Another 5-10% of causes are caused by germline mutations, with mutations in BRCA2 being the most frequent. Two background diseases increase the risk of pancreatic cancer-pancreatitis, and diabetes. Major challenges presented by this cancer are: 1) determination of the molecular pathways that make this cancer so aggressive; 2) development of new modalities, perhaps based on proteomics, to enhance early detection. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 39 条
[11]   DIABETES-MELLITUS AS A RISK FACTOR FOR PANCREATIC-CANCER - A METAANALYSIS [J].
EVERHART, J ;
WRIGHT, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (20) :1605-1609
[12]   Inflammatory mechanisms contributing to pancreatic cancer development [J].
Farrow, B ;
Sugiyama, Y ;
Chen, A ;
Uffort, E ;
Nealon, W ;
Evers, M .
ANNALS OF SURGERY, 2004, 239 (06) :763-769
[13]  
GHADIRIAN P, 1991, CANCER DETECT PREV, V15, P357
[14]   BRCA2 germline mutations in familial pancreatic carcinoma [J].
Hahn, SA ;
Greenhalf, B ;
Ellis, I ;
Sina-Frey, M ;
Rieder, H ;
Korte, B ;
Gerdes, B ;
Kress, R ;
Ziegler, A ;
Raeburn, JA ;
Campra, D ;
Grützmann, R ;
Rehder, H ;
Rothmund, M ;
Schmiegel, W ;
Neoptolemos, JP ;
Bartsch, DK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (03) :214-221
[15]   Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse [J].
Hingorani, SR ;
Petricoin, EF ;
Maitra, A ;
Rajapakse, V ;
King, C ;
Jacobetz, MA ;
Ross, S ;
Conrads, TP ;
Veenstra, TD ;
Hitt, BA ;
Kawaguchi, Y ;
Johann, D ;
Liotta, LA ;
Crawford, HC ;
Putt, ME ;
Jacks, T ;
Wright, CVE ;
Hruban, RH ;
Lowy, AM ;
Tuveson, DA .
CANCER CELL, 2003, 4 (06) :437-450
[16]  
HRUBAN RH, 1993, AM J PATHOL, V143, P545
[17]   Pancreatic intraepithelial neoplasia -: A new nomenclature and classification system for pancreatic duct lesions [J].
Hruban, RH ;
Adsay, NV ;
Albores-Saavedra, J ;
Compton, C ;
Garrett, ES ;
Goodman, SN ;
Kern, SE ;
Klimstra, DS ;
Klöppel, G ;
Longnecker, DS ;
Lüttges, J ;
Offerhaus, GJA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (05) :579-586
[18]   Aspirin use and pancreatic cancer mortality in a large United States cohort [J].
Jacobs, EJ ;
Connell, CJ ;
Rodriguez, C ;
Patel, AV ;
Calle, EE ;
Thun, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (07) :524-528
[19]  
Lal G, 2000, CANCER RES, V60, P409
[20]   Racial differences in pancreatic cancer: Comparison of survival and histologic types of pancreatic carcinoma in Asians, Blacks, and Whites in the United States [J].
Longnecker, DS ;
Karagas, MR ;
Tosteson, TD ;
Mott, LA .
PANCREAS, 2000, 21 (04) :338-343